|
Characteristic
|
OGTT in stroke (n = 59)
|
OGTT controls (n = 27)
|
Total rtPA cohort (n = 379)
|
|---|
|
Age, years
|
70.6 (61.5–76.2)
|
44.6 (27.9–68.3)
|
74.5 (65.3–83.3)
|
|
Male sex (%)
|
66.1
|
40.7
|
51.4
|
|
NIH before tPA
|
4 (3–6)
|
–
|
6 (3–12.5)
|
|
mRS discharge
|
1 (1–3)
|
–
|
2 (1–4)
|
|
BMI, kg/m2
|
26.2 (23.4–29.3)
|
22.7 (21.2–26.0)
|
24.9 (22.9–28.4)
|
|
eGFR, ml min−1 (1.73 m)−2
|
70 (59–76)
|
–
|
64 (51–76)
|
|
Admission glucose mmol/L
|
6.8 (6.0–7.5)
|
–
|
6.7 (5.9–8.0)
|
|
Hypertension
|
54%
|
–
|
56%
|
|
Systolic BP, mmHg
|
154 (140–176)
|
–
|
157 (140–173)
|
|
Diastolic BP, mmHg
|
89 (80–98.5)
|
–
|
83.5 (75–93)
|
|
Atrial fibrillation (%)
|
14
|
–
|
20
|
|
Current smokers (%)
|
10
|
–
|
12
|
|
Prev. diabetes (%)
|
0
|
0
|
15
|
|
Pathologic OGTT (%)
|
57.6
|
11.1
|
–
|
|
Normal glucose tolerance
|
42.4
|
88.9
|
–
|
|
Fasting hyperglycemia
|
18.6
|
3.7
|
–
|
|
Impaired glucose tolerance
|
52.5
|
11.1
|
–
|
|
Diabetes
|
5.1
|
0
|
–
|
- Values are medians (IQR) or %
